Abstract
Uncertainty about linkage phases of multiple single nucleotide polymorphisms (SNPs) in heterozygous diploids challenges the identification of specific DNA sequence variants that encode a complex trait. A statistical technique implemented with the EM algorithm has been developed to infer the effects of SNP haplotypes from genotypic data by assuming that one haplotype (called the risk haplotype) performs differently from the rest (called the non-risk haplotype). This assumption simplifies the definition and estimation of genotypic values of diplotypes for a complex trait, but will reduce the power to detect the risk haplotype when non-risk haplotypes contain substantial diversity. In this article, we incorporate general quantitative genetic theory to specify the differentiation of different haplotypes in terms of their genetic control of a complex trait. A model selection procedure is deployed to test the best number and combination of risk haplotypes, thus providing a precise and powerful test of genetic determination in association studies. Our method is derived on the maximum likelihood theory and has been shown through simulation studies to be powerful for the characterization of the genetic architecture of complex quantitative traits.
Keywords: Complex trait, diplotype, haplotype, quantitative genetics, quantitative trait nucleotides
Current Genomics
Title: A General Quantitative Genetic Model for Haplotyping a Complex Trait in Humans
Volume: 8 Issue: 5
Author(s): Song Wu, Jie Yang, Chenguang Wang and Rongling Wu
Affiliation:
Keywords: Complex trait, diplotype, haplotype, quantitative genetics, quantitative trait nucleotides
Abstract: Uncertainty about linkage phases of multiple single nucleotide polymorphisms (SNPs) in heterozygous diploids challenges the identification of specific DNA sequence variants that encode a complex trait. A statistical technique implemented with the EM algorithm has been developed to infer the effects of SNP haplotypes from genotypic data by assuming that one haplotype (called the risk haplotype) performs differently from the rest (called the non-risk haplotype). This assumption simplifies the definition and estimation of genotypic values of diplotypes for a complex trait, but will reduce the power to detect the risk haplotype when non-risk haplotypes contain substantial diversity. In this article, we incorporate general quantitative genetic theory to specify the differentiation of different haplotypes in terms of their genetic control of a complex trait. A model selection procedure is deployed to test the best number and combination of risk haplotypes, thus providing a precise and powerful test of genetic determination in association studies. Our method is derived on the maximum likelihood theory and has been shown through simulation studies to be powerful for the characterization of the genetic architecture of complex quantitative traits.
Export Options
About this article
Cite this article as:
Wu Song, Yang Jie, Wang Chenguang and Wu Rongling, A General Quantitative Genetic Model for Haplotyping a Complex Trait in Humans, Current Genomics 2007; 8 (5) . https://dx.doi.org/10.2174/138920207782446179
DOI https://dx.doi.org/10.2174/138920207782446179 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patent Selections
Recent Patents on DNA & Gene Sequences CD44-Targeting for Antitumor Drug Delivery: A New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis
Current Cancer Drug Targets The Structure and Main Functions of Aminopeptidase N
Current Medicinal Chemistry QSPR and Flow Cytometry Analysis (QSPR-FCA): Review and New Findings on Parallel Study of Multiple Interactions of Chemical Compounds with Immune Cellular and Molecular Targets
Current Drug Metabolism Carbohydrate Microarray Technology for Functional Glycomics
Current Chemical Biology Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery
Current Drug Targets Biologically Active Benzimidazole Derivatives
Mini-Reviews in Organic Chemistry The Potential Therapeutic Role of the HMGB1-TLR Pathway in Epilepsy
Current Drug Targets ExomiRs: A Novel Strategy in Cancer Diagnosis and Therapy
Current Gene Therapy Effect of Cytostatic Drugs on the mRNA Expression Levels of Ribonuclease κ in Breast and Ovarian Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Liposomal Drug Delivery: A Review
Pharmaceutical Nanotechnology Antioxidant Activity of Galantamine and Some of its Derivatives
Current Medicinal Chemistry Prospects of Developing Medicinal Therapeutic Strategies and Pharmaceutical Design for Effective Gluten Intolerance Treatment
Current Pharmaceutical Design Multi-Nuclear Platinum Drugs: A New Paradigm in Chemotherapy
Current Medicinal Chemistry - Anti-Cancer Agents Immunotherapy in Breast Cancer- Paving New Roads?
Current Molecular Pharmacology Anti-Cancer Potential of Some Commonly Used Drugs
Current Pharmaceutical Design Energy Balance and Carcinogenesis: Underlying Pathways and Targets for Intervention
Current Cancer Drug Targets The Oxido-reductase Activity of the Apoptosis Inducing Factor: A Promising Pharmacological Tool?
Current Pharmaceutical Design MicroRNA-372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Structural, Functional and Therapeutic Aspects of Snake Venom Metalloproteinases
Mini-Reviews in Organic Chemistry